NCT04692623View on ClinicalTrials.gov

EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 15, 2021

Study Completion Date

April 1, 2021

Conditions
Blood Glucose, LowHypoglycemia
Interventions
DRUG

Moxifloxacin 400mg

Blood will be checked for glucose levels and ECG at Baseline(Day Ist) and at Steady state Steady state(Tmax) via Glucometer and ECG machine will be used for determination of serum insulin levels.

DRUG

Gemifloxacin 320 MG

Blood will be checked for glucose levels and ECG at Baseline(Day Ist) and at Steady state(Tmax) via Glucometer and ECG machine will be used for determination of serum insulin levels.

Trial Locations (1)

091

Khyber Medical University,Peshawar, Peshawar

All Listed Sponsors
collaborator

Khyber Medical University Peshawar

OTHER

lead

Shaheed Benazir Bhutto University Sheringal Dir Upper

OTHER

NCT04692623 - EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY | Biotech Hunter | Biotech Hunter